Recent Finacing
Recent Raise
Kuros Biosciences develops and commercializes bone-regeneration and surgical biomaterials, including synthetic bone graft MagnetOs, drug–biologic spinal fusion candidate Fibrin‑PTH (KUR‑113), sealants (Neuroseal, KUR‑023), and orthobiologics.